Dr. Jessica Carmen joins with two decades of experience in the gene-based medicine sector.
RESILIENCE is a two-year program providing professional development to support the manufacturing of innovative medicines.
The addition of Phenocell’s offerings will help Axol advance its human disease models.
We're always looking for news.
